1. Comparison of the performances of low-crystalline carbonate apatite and Bio-Oss in sinus augmentation using three-dimensional image analysis
- Author
-
Manabu Okubo, Yurie Okuhama, Kei Fuchigami, Koudai Nagata, Kana Wakamori, Hiromasa Kawana, Hyunjin Kim, Hirokazu Sumitomo, and Ryoji Kitami
- Subjects
Molar ,Materials science ,Maxillary sinus augmentation ,Dental implant ,medicine.medical_treatment ,Sinus lift ,lcsh:Medicine ,Bone resorption ,03 medical and health sciences ,Imaging, Three-Dimensional ,0302 clinical medicine ,Apatites ,medicine ,Animals ,Humans ,Bio-Oss® ,Sinus (anatomy) ,Dental alveolus ,Minerals ,Research ,lcsh:R ,Cone-beam computed tomography ,CBCT ,030206 dentistry ,Maxillary Sinus ,Resorption ,lcsh:RK1-715 ,medicine.anatomical_structure ,030220 oncology & carcinogenesis ,lcsh:Dentistry ,Bone Substitutes ,Cattle ,Implant ,Cytrans® ,Biomedical engineering - Abstract
Background In locations where the alveolar bone height is low, such as at the maxillary molars, implant placement can be difficult, or even impossible, without procedures aimed at generating new bone, such as sinus lifts. Various types of bone graft materials are used after a sinus lift. In our study, a three-dimensional image analysis using a volume analyzer was performed to measure and compare the volume of demineralized bovine bone mineral (Bio-Oss®) and carbonate apatite (Cytrans®) after a sinus lift, as well as the amount of bone graft material resorption. Patient data were collected from cone-beam computed tomography images taken before, immediately following, and 6 months after the sinus lift. Using these images, both the volume and amount of resorption of each bone graft material were measured using a three-dimensional image analysis system. Results The amount of bone resorption in the Bio-Oss®-treated group was 25.2%, whereas that of the Cytrans®-treated group was 14.2%. A significant difference was found between the two groups (P < 0.001). Conclusions Our findings indicate that the volume of bone resorption was smaller in the Cytrans®-treated group than in the Bio-Oss®-treated group, suggesting that Cytrans® is more promising for successful implant treatments requiring a sinus lift.
- Published
- 2021